SEC Form 4 · accession 0001209191-18-022235
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John B Moriarty
Officer — EVP, General Counsel
Period of report
Mar 29, 2018
Accepted (ET)
Mar 30, 2018 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 29, 2018 | A | 25,000 | $0.00 | A | 25,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $32.66 | Mar 29, 2018 | A | 125,000 | A | — | Mar 28, 2028 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1Grant of Restricted Stock Units ("RSU") in consideration of services rendered. The RSU vests annually over three years commencing on March 1, 2019, subject to Reporting Person's Continuous Service as of each such date.
- F2The Option vests as follows: 25% of the shares shall vest one year from the Vesting Commencement Date of March 12, 2018, and the remaining shares shall vest ratably over the next 36 months.